We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical Faces Pricing Pressure, Currency Risks
Read MoreHide Full Article
On Sep 1, we issued an updated research report on chemical maker Eastman Chemical (EMN - Free Report) . .
Eastman Chemical’s revenues and profit slipped year over year in second-quarter 2016, hurt by lower selling prices. Adjusted earnings and sales missed the respective Zacks Consensus Estimate. The company saw lower prices across all businesses in the quarter.
Eastman Chemical, in its second-quarter call, said that it is benefiting from strong growth of its specialty products and its cost-cutting actions. However, the company is seeing increased competitive pressure and compressing olefin spreads. As such, the company sees a decline in adjusted earnings per share for 2016 that approaches 10% below adjusted earnings per share for 2015 compared with its earlier expectation of a decline of roughly 5%.
While Eastman Chemical is gaining from synergies of acquisitions, capacity additions and cost-cutting & productivity measures, it faces pricing pressure across its business segments as witnessed in the second quarter. Lower selling prices, especially in the Chemical Intermediates unit, hurt its revenues in the second quarter.
Soft pricing, in part, due to competitive pressure is affecting the company’s Chemical Intermediates segment. The company is seeing increased competitive pressure, especially from the Asia Pacific region, which is hurting prices.
Margins in the olefin business are expected to remain under pressure due to weak pricing. The depressed oil price environment and continued pressure on olefin spreads are expected to weigh on the company’s earnings in 2016. Weak methanol prices are also affecting prices for some acetyl and amines products.
Eastman Chemical also faces currency translation risks given a stronger U.S. dollar vis-à-vis a basket of currencies. Its revenues remain exposed to unfavorable currency swings. The company also faces headwind from challenging global economic conditions.
Some better-ranked companies in the chemical space include The Chemours Company (CC - Free Report) , Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) , all sporting a Zacks Rank #1 (Strong Buy).
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Eastman Chemical Faces Pricing Pressure, Currency Risks
On Sep 1, we issued an updated research report on chemical maker Eastman Chemical (EMN - Free Report) . .
Eastman Chemical’s revenues and profit slipped year over year in second-quarter 2016, hurt by lower selling prices. Adjusted earnings and sales missed the respective Zacks Consensus Estimate. The company saw lower prices across all businesses in the quarter.
Eastman Chemical, in its second-quarter call, said that it is benefiting from strong growth of its specialty products and its cost-cutting actions. However, the company is seeing increased competitive pressure and compressing olefin spreads. As such, the company sees a decline in adjusted earnings per share for 2016 that approaches 10% below adjusted earnings per share for 2015 compared with its earlier expectation of a decline of roughly 5%.
While Eastman Chemical is gaining from synergies of acquisitions, capacity additions and cost-cutting & productivity measures, it faces pricing pressure across its business segments as witnessed in the second quarter. Lower selling prices, especially in the Chemical Intermediates unit, hurt its revenues in the second quarter.
Soft pricing, in part, due to competitive pressure is affecting the company’s Chemical Intermediates segment. The company is seeing increased competitive pressure, especially from the Asia Pacific region, which is hurting prices.
Margins in the olefin business are expected to remain under pressure due to weak pricing. The depressed oil price environment and continued pressure on olefin spreads are expected to weigh on the company’s earnings in 2016. Weak methanol prices are also affecting prices for some acetyl and amines products.
Eastman Chemical also faces currency translation risks given a stronger U.S. dollar vis-à-vis a basket of currencies. Its revenues remain exposed to unfavorable currency swings. The company also faces headwind from challenging global economic conditions.
Eastman Chemical has a Zacks Rank #4 (Sell).
EASTMAN CHEM CO Price
EASTMAN CHEM CO Price | EASTMAN CHEM CO Quote
Stocks to Consider
Some better-ranked companies in the chemical space include The Chemours Company (CC - Free Report) , Innophos Holdings Inc and Innospec Inc. (IOSP - Free Report) , all sporting a Zacks Rank #1 (Strong Buy).
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>